
What We're Reading: COVID-19 Vaccine Expansion Halted; PBM Probe; High-Volume Antibiotic Prescribers
The FDA delays its decision on Pfizer/BioNTech’s COVID-19 vaccine in young children; the Federal Trade Commission (FTC) will vote on whether to investigate pharmacy benefit managers (PBMs); nearly half of high-volume antibiotic prescribers are located in Southern states.
FDA Seeks More Data on COVID-19 Vaccines in Children Under 5
FTC May Investigate PBMs’ Impact on Drug Prices
The US Federal Trade Commission (FTC) will vote Thursday about studying the impact that pharmacy benefit managers (PBMs) have on drug prices and the businesses of pharmacies. Reported by
Study Finds Nearly Half of High-Volume Antibiotic Prescribers in Southern States
The CDC's latest
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.